Non Small Cell Lung Cancer Clinical Trials

There are 18 registered clinical trials for Non Small Cell Lung Cancer in the TrialLens index.

Trials (18)

• Immunological Variables Associated to ICI Toxicity in Cancer Patients Phase 2 · Jules Bordet Institute
• Blood Testing to Detect Cancer Recurrence in Patients With Early-Stage Non-Small Cell Lung Cancer N/A · Fox Chase Cancer Center
• Bortezomib (PS-341) in Combination With Carboplatin and Docetaxel for Patients With Advanced Non-Small Cell Lung Cancer Phase 1 · Milton S. Hershey Medical Center
• 89Zr-girentuximab for PET Imaging of CAIX Positive Solid Tumors Phase 2 · Telix Pharmaceuticals (Innovations) Pty Ltd
• Comparing the Efficacy and Safety of a New Additional Treatment With Tislelizumab in Non-Small Cell Lung Cancer (NSCLC) Phase 3 · BeiGene
• GW786034 in Patients With Non Small Cell Lung Cancer 3rd Line Phase 2 · Illinois CancerCare, P.C.
• Isotoxic Intensity Modulated Radiotherapy (IMRT) in Stage III Non Small Cell Lung Cancer (NSCLC) - A Feasibility Study N/A · Prof Corinne Faivre-Finn
• Stereotactic Body Radiotherapy (SBRT) for Reirradiation of Inoperable Lung Lesions N/A · Istituto Clinico Humanitas
• Pembrolizumab and Itacitinib (INCB039110) for Non-Small Cell Lung Cancer Phase 2 · University of Pennsylvania
• Breath Analysis in Early Stage Lung Cancer Using Infrared Spectroscopy N/A · Breathe BioMedical Inc
• TGRX-1942 Chinese Phase I for Advanced Solid Tumor And/or Relapsed/Refractory Hematologic Malignancies Phase 1 · Shenzhen TargetRx Co., Ltd.
• Autologous Tumor DRibble Vaccine in Patients With Non-Small Cell Lung Cancer Phase 1 · Providence Health & Services
• Efficacy of Re-challenge With Immune-Checkpoints Inhibitors in Advanced Non-Small-Cell Lung Cancer Patients: a Retrospective Observational Study N/A · University Hospital, Grenoble
• 18F-T2 PET/CT Imaging for CAIX Positive Solid Tumors N/A · Peking University First Hospital
• A Study of Alimta/Cisplatin/Gefitinib for Asian Non-smoking Participants With Non Small Cell Lung Cancer Phase 3 · Eli Lilly and Company
• Trial of MEK Inhibitor and PI3K/mTOR Inhibitor in Subjects With Locally Advanced or Metastatic Solid Tumors Phase 1 · EMD Serono
• A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer Phase 1/2 · AEterna Zentaris
• A Study to Evaluate the Benefit of Adding Durvalumab After Chemotherapy, Durvalumab and Surgery in Patients With Early-stage, Operable, Non-small Cell Lung Cancer. Phase 3 · ETOP IBCSG Partners Foundation

Related landscapes

• Phase 1/2 Non Small Cell Lung Cancer
• Phase 2 Non Small Cell Lung Cancer
• Phase 3 Non Small Cell Lung Cancer
• N/A Non Small Cell Lung Cancer
• Phase 1 Non Small Cell Lung Cancer

Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.